BACKGROUND: We evaluated the relationship between diabetes and temporal characteristics of cardiac risk at long-term follow-up in a propensity score-matched cohort of diabetic and non-diabetic patients with normal stress myocardial perfusion single-photon emission computed tomography (MPS). METHODS AND RESULTS: We studied 828 consecutive patients with suspected or known coronary artery disease and normal perfusion at stress MPS. To account for differences in baseline characteristics between diabetics and non-diabetics, we created a propensity score-matched cohort considering clinical variables and stress type. After matching, clinical characteristics were comparable in 260 diabetic and 260 non-diabetic patients. All patients were followed for at least 1 year (median 53 months). End-point events were cardiac death or nonfatal myocardial infarction. At Cox analysis, diabetes (hazard ratio 3.9, P < .01) and post-stress left ventricular ejection fraction (LVEF) ≤45% (hazard ratio 4.1, P < .01) were independent predictors of events. At parametric analysis, non-diabetic patients with post-stress LVEF >45% remained at low risk for the entire length of follow-up, while the highest probability of events and the major risk acceleration was observed in patients with diabetes and post-stress LVEF ≤45%. CONCLUSIONS: After a normal stress MPS, diabetic patients are at higher risk for cardiac events than non-diabetic subjects also after balancing clinical characteristics and stress type by propensity score analysis. The warranty period of a normal stress MPS varies according to diabetic status and post-stress LVEF.
BACKGROUND: We evaluated the relationship between diabetes and temporal characteristics of cardiac risk at long-term follow-up in a propensity score-matched cohort of diabetic and non-diabeticpatients with normal stress myocardial perfusion single-photon emission computed tomography (MPS). METHODS AND RESULTS: We studied 828 consecutive patients with suspected or known coronary artery disease and normal perfusion at stress MPS. To account for differences in baseline characteristics between diabetics and non-diabetics, we created a propensity score-matched cohort considering clinical variables and stress type. After matching, clinical characteristics were comparable in 260 diabetic and 260 non-diabeticpatients. All patients were followed for at least 1 year (median 53 months). End-point events were cardiac death or nonfatal myocardial infarction. At Cox analysis, diabetes (hazard ratio 3.9, P < .01) and post-stress left ventricular ejection fraction (LVEF) ≤45% (hazard ratio 4.1, P < .01) were independent predictors of events. At parametric analysis, non-diabeticpatients with post-stress LVEF >45% remained at low risk for the entire length of follow-up, while the highest probability of events and the major risk acceleration was observed in patients with diabetes and post-stress LVEF ≤45%. CONCLUSIONS: After a normal stress MPS, diabeticpatients are at higher risk for cardiac events than non-diabetic subjects also after balancing clinical characteristics and stress type by propensity score analysis. The warranty period of a normal stress MPS varies according to diabetic status and post-stress LVEF.
Authors: Rory Hachamovitch; Sean Hayes; John D Friedman; Ishac Cohen; Leslee J Shaw; Guido Germano; Daniel S Berman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: Daniel S Berman; Xingping Kang; Sean W Hayes; John D Friedman; Ishac Cohen; Aiden Abidov; Leslee J Shaw; Aman M Amanullah; Guido Germano; Rory Hachamovitch Journal: J Am Coll Cardiol Date: 2003-04-02 Impact factor: 24.094
Authors: X Kang; D S Berman; H C Lewin; I Cohen; J D Friedman; G Germano; R Hachamovitch; L J Shaw Journal: Am Heart J Date: 1999-12 Impact factor: 4.749
Authors: Jane A Simonsen; Oke Gerke; Charlotte K Rask; Mohammad Tamadoni; Anders Thomassen; Søren Hess; Allan Johansen; Hans Mickley; Lisette O Jensen; Jesper Hallas; Werner Vach; Poul F Høilund-Carlsen Journal: J Nucl Cardiol Date: 2013-03-01 Impact factor: 5.952
Authors: Arend F L Schinkel; Henk J Boiten; Jors N van der Sijde; Pauline R Ruitinga; Eric J G Sijbrands; Roelf Valkema; Ron T van Domburg Journal: J Nucl Cardiol Date: 2012-06-08 Impact factor: 5.952
Authors: Roberta Green; Valeria Cantoni; Mario Petretta; Wanda Acampa; Mariarosaria Panico; Pietro Buongiorno; Giorgio Punzo; Marco Salvatore; Alberto Cuocolo Journal: J Nucl Cardiol Date: 2017-02-15 Impact factor: 5.952
Authors: Daniel S Berman; Piotr J Slomka; Donghee Han; Alan Rozanski; Heidi Gransar; Evangelos Tzolos; Robert J H Miller; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Lien-Hsin Hu; Damini Dey Journal: J Nucl Cardiol Date: 2021-11-10 Impact factor: 3.872